drugset / Trial / NCT00833638

A Study in Erectile Dysfunction

NCT00833638

Phase 4 Completed 372 enrolled Eli Lilly and Company
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine the day of onset of efficacy of tadalafil dosed once-a-day.

Timeline

Start
2009-02
Primary completion
2009-06
Completion
2009-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Tadalafil Small molecule 5 mg Oral

Indications